Remote Targets for Right Coronary Artery Bypass: Distal Trunk or Posterior Descending Artery Grafting

被引:0
作者
Songur, Murat C. [1 ]
Vural, Kerem M. [1 ]
Erdolu, Burak [1 ]
Ozyalcin, Sertan [1 ]
机构
[1] Yuksek Ihtisas Hosp Turkey, Cardiovasc Surg Dept, Ankara, Turkey
关键词
coronary artery bypass grafts surgery; CABG; atherosclerosis; restenosis; INTERNAL THORACIC ARTERY; OFF-PUMP; PATENCY; DISEASE;
D O I
10.1055/s-0033-1356865
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Choosing a good anastomotic site is crucial during surgical revascularization of the right coronary artery (RCA) system. In many instances of distal and/or sequential main trunk disease, either the right posterior descending coronary artery (RPDA) or distal part of the right main coronary artery (DRCA) is preferred as the target vessel. In this article, the saphenous vein graft (SVG) patency is compared between these two main targets in the long term. Materials and Methods Postoperative control coronary angiograms were obtained and assessed from 452 patients undergoing conventional on-pump coronary artery bypass grafting with either a DRCA (n = 305) or a RPDA graft (n = 147) after an average postoperative period of 5.8 +/- 4.3 years (range: 2 months-20 years; a total of 2,627 patient-years). Results The overall graft patency was 60%. The 15-year patency rate was better for the DRCA grafts than that for the RPDA grafts (32 +/- 5% vs. 19 +/- 6%, respectively; p = 0.001), irrespective of target vessel caliber. Other factors adversely influencing the long-term graft patency were poor target vessel quality (p = 0.002) and hypercholesterolemia (p = 0.01). On the other hand, target vessel diameter, diabetes mellitus, hypertension, chronic renal insufficiency, obesity, peripheral arterial disease, or SVG quality were not associated with poor long-term graft patency in these patients having distal-type RCA disease. Conclusions In the presence of distal and/or sequential right coronary disease, DRCA may be the target vessel of choice for bypass grafting, rather than the RPDA, mainly for better long-term SVG patency rates in this location.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 15 条
  • [1] Do angiographic results from symptom-directed studies reflect true graft patency?
    Buxton, BF
    Durairaj, M
    Hare, DL
    Gordon, I
    Moten, S
    Orford, V
    Seevanayagam, S
    [J]. ANNALS OF THORACIC SURGERY, 2005, 80 (03) : 896 - 901
  • [2] THE RELATION OF RISK-FACTORS TO THE DEVELOPMENT OF ATHEROSCLEROSIS IN SAPHENOUS-VEIN BYPASS GRAFTS AND THE PROGRESSION OF DISEASE IN THE NATIVE CIRCULATION - A STUDY 10 YEARS AFTER AORTOCORONARY BYPASS-SURGERY
    CAMPEAU, L
    ENJALBERT, M
    LESPERANCE, J
    BOURASSA, MG
    KWITEROVICH, P
    WACHOLDER, S
    SNIDERMAN, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (21) : 1329 - 1332
  • [3] Complementary saphenous grafting: Long-term follow-up
    Dion, R
    Glineur, D
    Derouck, D
    Verhelst, R
    Noirhomme, P
    El Khoury, G
    Degrave, E
    Hanet, C
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (02) : 296 - 304
  • [4] Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years
    FitzGibbon, GM
    Kafka, HP
    Leach, AJ
    Keon, WJ
    Hooper, GD
    Burton, JR
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (03) : 616 - 626
  • [5] SAPHENOUS-VEIN GRAFT PATENCY 1 YEAR AFTER CORONARY-ARTERY BYPASS-SURGERY AND EFFECTS OF ANTIPLATELET THERAPY - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY
    GOLDMAN, S
    COPELAND, J
    MORITZ, T
    HENDERSON, W
    ZADINA, K
    OVITT, T
    DOHERTY, J
    READ, R
    CHESLER, E
    SAKO, Y
    LANCASTER, L
    EMERY, R
    SHARMA, GVRK
    JOSA, M
    PACOLD, I
    MONTOYA, A
    PARIKH, D
    SETHI, G
    HOLT, J
    KIRKLIN, J
    SHABETAI, R
    MOORES, W
    ALDRIDGE, J
    MASUD, Z
    DEMOTS, H
    FLOTEN, S
    HAAKENSON, C
    HARKER, LA
    [J]. CIRCULATION, 1989, 80 (05) : 1190 - 1197
  • [6] Actual versus actuarial event-free percentages
    Grunkemeier, GL
    Wu, YX
    [J]. ANNALS OF THORACIC SURGERY, 2001, 72 (03) : 677 - 678
  • [7] KAY PH, 1985, BRIT HEART J, V54, P489
  • [8] Saphenous Vein Graft Disease: Review of Pathophysiology, Prevention, and Treatment
    Kim, Francis Y.
    Marhefka, Gregary
    Ruggiero, Nicholas J.
    Adams, Suzanne
    Whellan, David J.
    [J]. CARDIOLOGY IN REVIEW, 2013, 21 (02) : 101 - 109
  • [9] Limiting inflammatory response to cardiopulmonary bypass: pharmaceutical strategies
    Ng, Calvin S. H.
    Wan, Song
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (02) : 155 - 159
  • [10] FACTORS INFLUENCING PATENCY OF SAPHENOUS-VEIN GRAFTS
    ROTH, JA
    CUKINGNAN, RA
    BROWN, BG
    GOCKA, E
    CAREY, JS
    [J]. ANNALS OF THORACIC SURGERY, 1979, 28 (02) : 176 - 183